Neuromyelitis Optica Spectrum Disorders and Aquaporin-4 Pathophysiology

Neuromyelitis Optica Spectrum Disorders (NMOSD) are rare autoimmune inflammatory diseases of the central nervous system characterised by severe episodes of optic neuritis and transverse myelitis. Central to NMOSD pathophysiology is the water-channel protein aquaporin-4 (AQP4), predominantly expressed on astrocyte endfeet at the blood–brain barrier. Autoantibodies targeting AQP4 trigger a complement-dependent cascade resulting in astrocyte injury, secondary oligodendrocyte damage, demyelination and neuronal loss. Breakdown of immune tolerance in both B cell and T cell compartments underlies the generation of pathogenic AQP4-IgG. Recent work has elucidated mechanisms of B cell antigen presentation, T helper 17 polarisation and the interplay of interleukin-6 and type I interferons in disease propagation. These insights have informed targeted therapies—monoclonal antibodies against complement components, interleukin-6 receptor and B cell surface markers—which demonstrate substantial relapse reduction in AQP4-seropositive patients. Current research seeks to refine understanding of early tolerance failure, lesion heterogeneity and combinatorial immunomodulation to improve long-term neurological outcomes globally.

Research from Nature Portfolio

Recent studies have revealed that activated B cells express and present endogenous AQP4 in a CD40-dependent manner, mediating negative selection of AQP4-reactive T cells within the thymus. Conditional deletion of AQP4 in B cells permits the survival of autoreactive T cell clones, facilitating subsequent autoantibody production. Integrated transcriptomic and proteomic analyses have further shown that type I interferon signalling cooperates with interleukin-6 and B cell-derived cytokines to drive differentiation of pathogenic T helper 17 cells. This cascade explains the paradoxical coexistence of interferon signatures and Th17-driven pathology in NMOSD and highlights biomarkers predictive of response to B cell-depleting therapies.

Neuromyelitis Optica Spectrum Disorders and Aquaporin-4 Pathophysiology publication trend

The graph below shows the total number of articles in neuromyelitis optica spectrum disorders and aquaporin-4 pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Aquaporin-4 (AQP4): A water-channel protein expressed on astrocyte endfeet that regulates water homeostasis and serves as the primary autoantigen in NMOSD.

Neuromyelitis Optica Spectrum Disorder (NMOSD): An autoimmune disease characterised by optic neuritis and transverse myelitis, associated with pathogenic AQP4-IgG.

Autoantibody: An antibody produced by the immune system that mistakenly targets a self antigen, such as AQP4 in NMOSD.

Complement cascade: A series of plasma proteins that, once activated by antibody binding, form membrane attack complexes leading to cell lysis and inflammation.

Th17 cells: A subset of CD4+ T helper cells producing interleukin-17, implicated in driving central nervous system inflammation in NMOSD.

Germinal centre: A specialised microenvironment within secondary lymphoid tissues where B cells undergo affinity maturation and class-switch recombination.

References

1. B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. Nature (2024).
2. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. Journal of Neuroinflammation (2021).
3. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica. Brain (2018).
4. Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Annals of Neurology (2012).
5. Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica. Nature Communications (2020).